These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9004778)

  • 1. Colon-specific prodrugs of 5-radioiodo-2'-deoxyuridine.
    Baranowska-Kortylewicz J; Kortylewicz ZP; Hoffman D; Winoto A; Lai J; Dalrymple GV
    Acta Oncol; 1996; 35(7):959-64. PubMed ID: 9004778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrugs in site-selective delivery of radiopharmaceuticals.
    Baranowska-Kortylewicz J; Kortylewicz ZP; Hoffman D; Dalrymple GV
    Q J Nucl Med; 1997 Jun; 41(2):127-39. PubMed ID: 9203852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
    Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
    Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
    Bagshawe KD; Sharma K; Southall PJ; Boden JA; Boxer GM; Patridge TA; Antoniw P; Pedley RB
    Br J Radiol; 1991 Jan; 64(757):37-44. PubMed ID: 1998836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug glycosides: potential prodrugs for colon-specific drug delivery.
    Friend DR; Chang GW
    J Med Chem; 1985 Jan; 28(1):51-7. PubMed ID: 3965714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
    Haeberlin B; Rubas W; Nolen HW; Friend DR
    Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery.
    Uekama K; Minami K; Hirayama F
    J Med Chem; 1997 Aug; 40(17):2755-61. PubMed ID: 9276021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular prodrugs. XVI. Colon-targeted delivery--comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract.
    Larsen C; Harboe E; Johansen M; Olesen HP
    Pharm Res; 1989 Dec; 6(12):995-9. PubMed ID: 2622863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible contribution of beta-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells.
    Arafa HM
    Invest New Drugs; 2010 Jun; 28(3):306-17. PubMed ID: 19415182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
    McLeod AD; Friend DR; Tozer TN
    J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
    El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
    Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
    Minami K; Hirayama F; Uekama K
    J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo therapy of neoplastic meningitis with methotrexate and 5.
    Kassis AI; Dahman BA; Adelstein SJ
    Acta Oncol; 2000; 39(6):731-7. PubMed ID: 11130012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine.
    Kassis AI; Guptill WE; Taube RA; Adelstein SJ
    J Nucl Biol Med (1991); 1991; 35(3):167-73. PubMed ID: 1840093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease.
    Carrette O; Favier C; Mizon C; Neut C; Cortot A; Colombel JF; Mizon J
    Dig Dis Sci; 1995 Dec; 40(12):2641-6. PubMed ID: 8536525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma-targeted delivery system (part 2): Synthesis, radioiodination and biological evaluation in B16F0 bearing mice.
    El Aissi R; Miladi I; Chezal JM; Chavignon O; Miot-Noirault E; Moreau E
    Eur J Med Chem; 2016 Sep; 120():304-12. PubMed ID: 27214141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
    Humm JL; Bagshawe KD; Sharma SK; Boxer G
    Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria.
    Friend DR; Chang GW
    J Med Chem; 1984 Mar; 27(3):261-6. PubMed ID: 6699871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
    Nolen H; Fedorak RN; Friend DR
    J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
    Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
    J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.